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linical Characteristics of Patients Receiving Refurbished PacemakersTable 1 Clinical Characteristics of Patients Receiving Refurbished Pace
Patient # Age (Yrs) Sex
Pacemaker
Indication Clinical Sympto
1 68 M Sick sinus syndrome Syncope
2 74 M Third-degree block Dyspnea
3 70 M Sick sinus syndrome Pre-syncope
4 28 F Third-degree block Syncope
5 76 F Third-degree block Syncope
6 47 F Third-degree block Syncope
7 65 F Third-degree block Syncope
8 55 M Third-degree block Syncope
9 60 F Third-degree block Syncope
10 61 M Third-degree block Syncope
11 55 F Third-degree block Syncope
12 82 F Third-degree block Syncope
Required transvenous pacing before device placement; †patient had syncopal episodes for 1 year
emained in hospital for 15 days with transvenous pacemaker while waiting for procurement of dhe right ventricular outflow tract (RVOT)/subtricuspid region,
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rs
Device
Manufacturer
Single Versus
Dual Chamber Complications Notable Events
Medtronic Single None —
St. Jude Medical Dual None —
Biotronik Dual None —
Medtronic Single None —
Medtronic Single None *†
Medtronic Single None ‡
St. Jude Medical Single None *§
St. Jude Medical Single None †
St. Jude Medical Dual None —
St. Jude Medical Dual None —
St. Jude Medical Single None †
Biotronik Single None *
device placement; ‡device was placed due to end of battery life on previous pacemaker; §patienterved as a consultant to Ablation Frontiers; and has received research grants from St.
ude Medical, Inc. and Boston Scientific.
Key Words: pacemaker reuse y health care disparity y low- and
middle-income countries.
Letters to the Editorhe Right Ventricular Outflow
ract in Arrhythmogenic Right
entricular Cardiomyopathy
alal et al. (1) describe the accordion sign in family members
f arrhythmogenic right ventricular dysplasia/cardiomyopathy
ARVD/C) probands as a promising tool for the early diagnosis of
he disease. Besides this qualitative feature, which also was seen inhey also mention that quantitative right ventricular parameters
ended to be abnormal in those with 1 criteria point in their
eclassified approach. However, they do not mention whether the
VOT was enlarged in this cohort, a fact we find surprising
ecause in a previous study (2) from the same group, 66% of
atients with ARVD/C had an enlarged RVOT measured on
tandard axial images.
Given the fact that Corrado et al. (3) have suggested that an
arly/minor form of ARVD/C may primarily involve the RVOT,
imicking idiopathic RVOT tachycardia, we believe that quanti-make
msative assessment of the RVOT should always be part of the
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October 13, 2009:1557–9valuation of these patients, especially if we are trying to uncover
he early manifestations of the disease. Localized dilation of the
VOT detected by cardiovascular magnetic resonance also was
resent in another study involving 200 probands and relatives (4).
f RVOT dilation is present in the group where the accordion sign
as detected, it will be a quantitative parameter of the right
entricle that may also help in the early diagnosis of ARVD/C.
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eply
e are thankful to Drs. Thomas and Tavares for their interest in
ur study (1). Affliction of the right ventricular outflow track
RVOT) in arrhythmogenic right ventricular dysplasia/cardio-
yopathy (ARVD/C) has been well documented since its first
escription and also in subsequent reports (2–4). In our earlier
eport, each of the 15 ARVD/C patients presented with left
undle branch block-type ventricular tachycardia and had an
stablished diagnosis of ARVD/C (3). Similarly, Sen-Chowdhry
t al. (4) also relied on fulfillment of ARVD/C diagnostic criteria
or inclusion in their study. It comes as no surprise that there was
greater proportion of patients with RVOT dilation in these study
opulations compared with our present report. For identification
f early morphologic variants of ARVD/C, our present study wasarefully designed to exclude individuals with advanced disease.
xclusion of the probands resulted in a study population that
omprised, mostly, of asymptomatic family members who had
ever sought medical attention for cardiac symptoms (1). None of
hese patients had a dilated RVOT similar to that described
reviously (3).
Corrado et al. (5) used electroanatomic voltage mapping to
emonstrate that early ARVD/C may manifest as RVOT tachy-
ardia in the absence of right ventricular dilation. Notably, in the
ame study, there was no significant difference in the RVOT
iameter between patients with and without abnormal electroana-
omic voltage maps (5). From our investigation of probands in the
resent study (excluded in the main analysis), it appears that the
ccordion sign may be a precursor of aneurysmal dilation (1). In
onsidering this, we believe that quantitative evaluation of RVOT
oes not help quantify the accordion sign itself but the deteriora-
ion of right ventricular function in the “triangle of dysplasia”
ssociated with advancing disease.
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